Skip to main content
Masahiro Ono, MD, Thoracic Surgery, Austin, TX, Ascension Seton Medical Center Austin

MasahiroOnoMDPhD

Thoracic Surgery Austin, TX

Adult Cardiac Surgery, Cardiopulmonary Transplantation

University of Texas at Austin Dell Medical School

Dr. Ono is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Ono's full profile

Already have an account?

Summary

  • Dr. Masahiro Ono is a thoracic surgeon in Austin, TX and is affiliated with multiple hospitals in the area, including Ascension Seton Medical Center Austin. He also speaks multiple languages, including Japanese. He specializes in adult cardiac surgery and cardiopulmonary transplantation and is experienced in cardiogenic shock, ventricular assist device implantation, extracorporeal membrane oxygenation, adult cardiac surgery, and lung transplant surgery.

Education & Training

  • Texas Heart Institute
    Texas Heart InstituteFellowship, Thoracic Surgery, 2013 - 2016
  • Johns Hopkins University
    Johns Hopkins UniversityCardiac Surgery, 2010 - 2013
  • Showa University School of Medicine
    Showa University School of MedicinePh.D., 2009

Certifications & Licensure

  • NM State Medical License
    NM State Medical License 2020 - 2026
  • TX State Medical License
    TX State Medical License 2018 - 2025

Awards, Honors, & Recognition

  • Branislav Radovancevic Memorial Fellowship Grant Award International Society for Heart & Lung Transplantation, 2013
  • 14th Annual ACCM Research Day Academic Award Johns Hopkins Hospital, 2012
  • 17th Annual Anselm Talalay Vincent Gott Cardiac Research Prize Winner Johns Hopkins Hospital, 2011
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Impaired Olfaction and Risk for Delirium or Cognitive Decline After Cardiac Surgery  
    Brown C, Morrissey C, Ono M, Yenokyan G, Selnes O, Walston J, Max L, LaFlam A, Neufeld K, Gottesman RF, Hogue CW, Journal of the American Geriatric Society, 1/1/2015
  • Effect of carotid revascularization on cerebral autoregulation in combined cardiac surgery  
    Hori D, Ono M, Adachi H, Hogue CW, Eur J Cardiothorac Surg, 1/1/2015
  • Hypotension After Cardiac Operations Based on Autoregulation Monitoring Leads to Brain Cellular Injury  
    Hori D, Ono M, Rappold TE, Conte JV, Shah AS, Cameron DE, Adachi H, Everett AD, Hogue CW, Annals of Thoracic Surgery, 1/1/2015
  • Join now to see all

Abstracts/Posters

  • Preoperative Risk Factors for Stroke After HeartWare Left Ventricular Assist Device Implantation: Texas Heart Institute Experience
    Ono M, Singh SK, Cohn WE, Civitello AB, Frazier OH, 36th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation, Washington, DC, 1/27/2016
  • Individual Optimal Blood Pressure Determined by Cerebral Autoregulation Monitoring During and After Continuous-Flow Left Ventricular Assist Device Implantation
    Ono M, Singh SK, Kibler KK, Easley RB, Brady KM, 36th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation, Washington, DC, 1/27/2016
  • Optimal Blood Pressure during Cardiopulmonary Bypass defined by Cerebral Autoregulation Monitoring and its association with Severe Coronary Artery Disease
    Hori D, Nomura Y, Ono M, Joshi B, Mandal K, Cameron ED, Hogue CW, 96th Annual Meeting of the American Association for Thoracic Surgery, Baltimore, MD, 1/14/2016
  • Join now to see all

Lectures

  • Current LVAD state in USA and Texas Heart Institute 
    Tokyo, Japan - 1/1/2015
  • Cerebral Protection and Autoregulation during Cardiopulmonary Bypass - What Do We Not Know? 
    Brussels, Belgium - 1/1/2014

Press Mentions

  • Multi-Center, Multi-Society Study of Impella-Supported Patients with Cardiogenic Shock Due to Myocarditis in Japan Achieves 30-Day Survival of 77%
    Multi-Center, Multi-Society Study of Impella-Supported Patients with Cardiogenic Shock Due to Myocarditis in Japan Achieves 30-Day Survival of 77%September 20th, 2022
  • Triple Therapy Demonstrates 100% Cure Rate in Mouse Model of Melanoma
    Triple Therapy Demonstrates 100% Cure Rate in Mouse Model of MelanomaMay 26th, 2022
  • Auf Der STS-Jahrestagung Vorgestellte Umfangreiche Klinische Studie Zeigt Überlebensrate Von 79 % Bei Behandlung Mit Impella 5.5 Mit SmartAssist Herzpumpe
    Auf Der STS-Jahrestagung Vorgestellte Umfangreiche Klinische Studie Zeigt Überlebensrate Von 79 % Bei Behandlung Mit Impella 5.5 Mit SmartAssist HerzpumpeFebruary 1st, 2021
  • Join now to see all

Other Languages

  • Japanese

Hospital Affiliations